Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Breast Cancer
Breast Cancer
Novel T-DM1 Prolongs Remission in Metastatic Breast Cancer: A New “Smart Bomb”
Audrey Andrews
Play Video
Breast Cancer
Olaparib First PARP Inhibitor to Show Advantage in BRCA-Positive Breast Cancer
Wayne Kuznar
Play Video
Breast Cancer
Pembrolizumab Added to First-Line Chemotherapy Improves Progression-Free Survival in Metastatic TNBC
Chase Doyle
Wayne Kuznar
Play Video
Breast Cancer
,
FDA Approvals
,
In the News
,
Select Drug Profiles
Proposed Landmark Policy Changes to Modernize Mammography and Raise Breast Density Awareness
Play Video
Breast Cancer
Radiation May Be Safely Omitted in Favorable-Risk Breast Cancer Patients Aged 50 to 69 Years
Phoebe Starr
Play Video
Breast Cancer
Regional Lymph Node Irradiation Indicated for Early Breast Cancer
Play Video
Breast Cancer
Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer
Lowell L Hart, MD
Play Video
Breast Cancer
Sacituzumab Govitecan Improves Progression-Free Survival in Metastatic Triple-Negative Breast Cancer with Brain Metastases
Phoebe Starr
Play Video
Breast Cancer
,
FDA Approvals
,
In the News
,
Multiple Myeloma
,
Pediatric Cancer
,
Select Drug Profiles
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Play Video
1
2
3
Page 3 of 3
Results 21 - 29 of 29